Literature DB >> 19454071

Acute respiratory distress syndrome.

Satyendra Sharma1.   

Abstract

INTRODUCTION: Acute respiratory distress syndrome (ARDS) is characterised by lung inflammation with severe hypoxia, which usually develops over 4-48 hours and persists for days or weeks. The main causes of ARDS are infections, aspiration of gastric contents, and trauma. Between a third and a half of people with ARDS die from the disease, but mortality depends on the underlying cause. Some survivors have long-term respiratory or cognitive problems. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of interventions in adults with acute respiratory distress syndrome? We searched: Medline, Embase, The Cochrane Library and other important databases up to August 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 21 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: corticosteroids, low tidal volume mechanical ventilation, nitric oxide, prone position, and protective ventilation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19454071      PMCID: PMC2943799     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  47 in total

Review 1.  Mechanical ventilation in acute lung injury and acute respiratory distress syndrome.

Authors:  R G Brower; H E Fessler
Journal:  Clin Chest Med       Date:  2000-09       Impact factor: 2.878

Review 2.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

3.  Impairment after adult respiratory distress syndrome. An evaluation based on American Thoracic Society recommendations.

Authors:  A J Ghio; C G Elliott; R O Crapo; S L Berlin; R L Jensen
Journal:  Am Rev Respir Dis       Date:  1989-05

4.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

5.  Adult respiratory distress syndrome: risk with common predispositions.

Authors:  A A Fowler; R F Hamman; J T Good; K N Benson; M Baird; D J Eberle; T L Petty; T M Hyers
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

6.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

7.  Clinical risks for development of the acute respiratory distress syndrome.

Authors:  L D Hudson; J A Milberg; D Anardi; R J Maunder
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

8.  Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993.

Authors:  J A Milberg; D R Davis; K P Steinberg; L D Hudson
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

9.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09

Review 10.  Epidemiology of acute lung injury and acute respiratory distress syndrome.

Authors:  Fernando Frutos-Vivar; Nicolás Nin; Andrés Esteban
Journal:  Curr Opin Crit Care       Date:  2004-02       Impact factor: 3.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.